What to watch with CYP2C19 and sleep?

CYP2C19 is a cytochrome P450 enzyme primarily involved in metabolizing drugs such as clopidogrel, proton pump inhibitors, and certain antidepressants. A direct, well-established link between CYP2C19 variants and sleep quality or sleep disorders is lacking in the scientific literature. Some studies suggest a possible indirect role through the metabolism of endogenous compounds or medications that affect sleep (e.g., some benzodiazepines or SSRIs), but effect sizes are small and findings inconsistent. Consumer DNA tests reporting CYP2C19 status cannot reliably predict personal sleep patterns. For sleep issues, clinical factors (stress, sleep hygiene, hormone levels) should be evaluated first. The evidence for a direct genetic influence of CYP2C19 on sleep is currently weak to unclear.